ONS Testimony for FDA Public Opioid REMS Meeting

Wednesday, May 27, 2009

May 27th and 28th - The Food and Drug Administration (FDA) held a public meeting to hear feedback from individuals and groups related to the possibility that the FDA will create a Risk Evaluation and Mitigation Strategies (REMS) for certain opioid drugs. This is a synopsis of the testimony ONS delivered to the FDA on May 27th, 2009.

May 27th, 2009 ONS Testimony for FDA Public Opioid REMS Meeting